Clinical trial

Bupropion and Counseling With or Without Contingency Management to Enhance…

NCT00079469 · National Institutes of Health Clinical Center (CC), NIH · Completed

Key facts

NCT number NCT00079469
Title Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke
Official title Contingency Management to Enhance Smoking Cessation for Cancer Survivors: A Proof of Concept Trial
Lead sponsor National Institutes of Health Clinical Center (CC), NIH
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Interventional
Conditions Cancer Survivor, Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Behavioral, Drug
Interventions smoking cessation intervention, bupropion hydrochloride
Start date Feb 1, 2004
Completion Aug 1, 2004
First posted Mar 10, 2004
Last update posted Mar 8, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies